logo

For the Inventor, By the Inventor

Rockville, MD, United States of America

Sanaria Inc.

USPTO Granted Patents = 26

% Expired Patents = 7.7



Trademarks = 1

Forward Citations = 138

Loading Chart...
Loading Chart...

44 inventors (with patents filed for the assignee):

goldMedal Stephen L Hoffman (22 out of 34 patents)

silverMedal B Kim Lee Sim (8 out of 11 patents)

bronzeMedal Richard E Stafford (7 out of 8 patents)

4.  Minglin Li (7 out of 7 patents)

5.  Abraham G Eappen (5 out of 5 patents)

6.  Sumana Chakravarty (4 out of 4 patents)

7.  Robert Seder (3 out of 9 patents)

8.  Eric R James (3 out of 3 patents)

9.  Russell H Taylor (2 out of 85 patents)

10.  Iulian Ioan Iordachita (2 out of 23 patents)

11.  Neville Kisalu (2 out of 2 patents)

12.  Azza Idris (2 out of 2 patents)

13.  Barbara Flynn (2 out of 2 patents)

14.  Gregory Chirikjian (2 out of 7 patents)

15.  Moriya Tsuji (2 out of 13 patents)


Core Competencies:
Cryogenic Storage
Mosquito Egg Cryopreservation
Live Attenuated Vaccine
Plasmodium Sporozoites
Neutralizing Antibodies
Automated Extraction Device
Serum Antibody Assay
Genetic Attenuation
Vaccine Compositions
Haematophagous Organisms

26 patents:

1. 12528084 - Container and cap assembly for cryogenic storage (2026-01-20),
2. 12484575 - Mosquito egg cryopreservation (2025-12-02),
3. 12409213 - Live attenuated oral vaccine against shigellosis and typhoid fever (2025-09-09),
4. 12171822 - Infectious plasmodium sporozoites grown in vitro (2024-12-24),
5. 11883475 - Infectioussporozoites grown in vitro (2024-01-30),
6. 11760794 - Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use (2023-09-19),
7. 11503819 - Apparatus and method of use for an automated mosquito salivary gland extraction device (2022-11-22),
8. 11207395 - Infectious plasmodium sporozoites grown in vitro (2021-12-28),
9. 11021535 - Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use (2021-06-01),
10. 10995980 - Cryovial storage system (2021-05-04),
11. 10781419 - Mosquito salivary gland extraction device and methods of use (2020-09-22),
12. 10441646 - Infectious plasmodium sporozoites grown in vitro (2019-10-15),
13. 10272146 - Purified plasmodium and vaccine compositions (2019-04-30),
14. 10197577 - Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines (2019-02-05),
15. 9931389 - Genetic attenuation of plasmodium by B9 gene disruption (2018-04-03),
Company Overview
Sanaria Inc. is a biotechnology company based in Rockville, Maryland, specializing in the development of innovative malaria vaccines. The organization focuses on harnessing advanced research in immunology and vaccine technology to create effective solutions for malaria prevention. Sanaria's proprietary platform aims to provide a safe and efficacious vaccine that can significantly reduce the global burden of malaria, a disease that continues to impact millions worldwide. Through its commitment to scientific excellence, Sanaria is positioned at the forefront of malaria vaccine development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Sanaria Inc. USPTO Patent Assignee Logo
26 Patents

#28 in Rockville, MD

#163 in Maryland

#12,865 in US

#24,826 in the World

Rockville, MD (US)
Rockville, MD, United States of America

Sanaria Inc.

Forward Citations = 138

44 inventors:

goldMedal Stephen L Hoffman (22 out of 34 patents)

silverMedal B Kim Lee Sim (8 out of 11 patents)

bronzeMedal Richard E Stafford (7 out of 8 patents)

4.  Minglin Li (7 out of 7 patents)

5.  Abraham G Eappen (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sanaria Inc.. Retrieved from https://idiyas.com/company/sanaria

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…